NCT00122473View on ClinicalTrials.gov

Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

January 31, 2007

Conditions
Dermatofibrosarcoma
Interventions
DRUG

Imatinib (Glivec)

Trial Locations (4)

21614

Department of Dermatology, ElbeKliniken - Klinikum Buxtehude, Buxtehude

66424

Department of Dermatology, The Saarland University Hospital, Homburg/Saar

68167

Skin Cancer Unit, German Cancer Research Center and Department of Dermatology, University Hospital of Mannheim, Mannheim

06097

Department of Dermatology, Martin-Luther-University Halle-Wittenberg, Halle

All Listed Sponsors
lead

Dermatologic Cooperative Oncology Group

OTHER

NCT00122473 - Imatinib in Dermatofibrosarcoma Protuberans (DFSP) | Biotech Hunter | Biotech Hunter